August 2025

B.S. 4 years programme /BPharm/MBBS/Integrated BS-MS/MSc/BE/BTech or equivalent degree, with 55% marks and passing of NET/GATE test.

B. Pharm / Pharm D or equivalent. Experience in Operations / Patient Care management 

PG in Life Sciences / Biology or an associated field, possesses National Eligibility Tests- CSIR UGC NET including Lectureship and GATE certificate or qualified National Level examination conducted by Central Government departments/agencies /institutions

B.Pharm or Equivalent from recognized Institution. The Blinatumomab Project has been envisioned as a multicentric project which facilitates treatment for relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in adults and children.

Postgraduate degree in Life Sciences / Biology or an associated field, possesses National Eligibility Tests- CSIR UGC NET including Lectureship and GATE certificate or qualified National Level examination conducted by Central Government departments

M.Sc. in Botany, Biotechnology, Biochemistry, Plant Science from a recognized University or equivalent.

Graduate Degree in Biotechnology or any Life Sciences subject from a recognized University or equivalent. Understanding the Molecular Mechanism in Ceramide Induced Pathological Activation of Nek7/Nlrp3-Inflammasome. 

Bachelor of Science (B.Sc) with biology as main subject, Bachelors in Engineering with biotechnology (MSc) with minimum 55% of total marks (equivalent grade) in Molecular biology, Genetics, Biochemistry, Biotechnology.

M. Sc. in Chemistry, Biotechnology, Microbiology, Bioinformatics. Work experience in synthesis of nanomaterials, nanocomposites, membrane design etc.